Sequential Curettage, 5-Fluorouracil, and Photodynamic Therapy for Field Cancerization of the Scalp and Face in Solid Organ Transplant Recipients

Dermatol Surg. 2016 Jan:42 Suppl 1:S66-72. doi: 10.1097/DSS.0000000000000589.

Abstract

Background: Field cancerization with actinic keratoses and squamous cell carcinoma in situ (AK/SCCIS) represents a common therapeutic challenge in solid organ transplant recipients (SOTRs). These patients often show inadequate responses to methods traditionally used as monotherapy (e.g., topical chemotherapy).

Objective: To describe the clinical outcomes and feasibility of a sequential approach to treatment of field cancerization in SOTRs.

Methods: Four SOTRs with field cancerization of the scalp and/or face were treated using a sequential approach. Light curettage of hypertrophic lesions was followed by application of 5-fluorouracil 5% cream twice daily for 5 days and photodynamic therapy (PDT) with 1-hour incubation on day 6. Pain level during and after PDT was recorded. Photographs were obtained immediately before and after treatment and at follow-up appointments.

Results: All 4 patients tolerated this approach well and demonstrated excellent responses to treatment with complete or near-complete clinical resolution of AK/SCCIS lesions. Patients remained free of AK/SCCIS based on clinical examination 1 to 6 months after treatment.

Conclusion: For SOTRs with field cancerization, sequential therapy represents a viable therapeutic regimen with good tolerability and durable clinical response. This approach warrants further investigation to determine which therapeutic combinations have optimal tolerability and efficacy.

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Carcinoma in Situ / therapy
  • Carcinoma, Squamous Cell / therapy
  • Combined Modality Therapy
  • Curettage*
  • Facial Neoplasms / therapy*
  • Fluorouracil / therapeutic use*
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Keratosis, Actinic / therapy
  • Organ Transplantation*
  • Photochemotherapy*
  • Risk Factors
  • Scalp*
  • Skin Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil